A pH-responsive mesoporous silica nanoparticles-based multi-drug delivery system for overcoming multi-drug resistance

Biomaterials

Volumn 32, Issue 30, 2011, Pages 7711-7720

  He, Qianjun ^a   Gao, Yu ^b   Zhang, Lingxia ^a   Zhang, Zhiwen ^b   Gao, Fang ^b   Ji, Xiufeng ^b   Li, Yaping ^b   Shi, Jianlin ^a  

^a SHANGHAI INSTITUTE OF CERAMICS   (China)

^b SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Controlled drug release; Mesoporous silica; Multi drug delivery; Multi drug resistance; Nanoparticle; One pot self assembly

Indexed keywords

CONTROLLED DRUG RELEASE; MESOPOROUS SILICA; MULTI-DRUG DELIVERY; MULTIDRUG RESISTANCE; ONE POT;

DISEASES; DRUG DELIVERY; MESOPOROUS MATERIALS; MICELLES; NANOPARTICLES; SELF ASSEMBLY; SILICA; SURFACE ACTIVE AGENTS;

PHARMACODYNAMICS;

DOXORUBICIN; NANOCARRIER; SILICON DIOXIDE; SURFACTANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL STRAIN; CELL STRAIN ADR; CELL STRAIN MCF 7; CHEMOSENSITIZATION; CONTROLLED STUDY; DISPERSION; DRUG DELIVERY SYSTEM; DRUG RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MICELLE; MOUSE; NONHUMAN; PARTICLE SIZE; PH; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CELL LINE, TUMOR; DELAYED-ACTION PREPARATIONS; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HUMANS; HYDROGEN-ION CONCENTRATION; MICE; MICE, NUDE; MICELLES; NANOPARTICLES; NEOPLASMS; SILICON DIOXIDE; SURFACE-ACTIVE AGENTS;

EID: 80051544002     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.06.066     Document Type: Article

References (34)

1. Jemal A., Center M.M., DeSantis C., Ward E.M. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidem Biomar 2010, 19:1893-1907.
2. Lage H. An overview of cancer multidrug resistance: a still unsolved problem. Cell Mol Life Sci 2008, 65:3145-3167.
3. Ullah M.F. Cancer multidrug resistance (MDR): a major impediment to effective chemotherapy. Asian Pac J Cancer Prev 2008, 9:1-6.
4. Page R., Takimoto C. Cancer management: a multidisciplinary approach: medical, surgical, and radiation oncology. Principles of chemotherapy. 8 2004, 21-38. PRR, New York. R. Pazdur (Ed.).
5. Shabbits J.A., Hu Y.P., Mayer L.D. Tumor chemosensitization strategies based on apoptosis manipulations. Mol Cancer Ther 2003, 2:805-813.
6. van Vlerken L.E., Duan Z.F., Seiden M.V., Amiji M.M. Modulation of intracellular ceramide using polymeric nanoparticles to overcome multidrug resistance in cancer. Cancer Res 2007, 67:4843-4850.
7. Barraud L., Merle P., Soma E., Lefrançois L., Guerret S., Chevallier M., et al. Increase of doxorubicin sensitivity by doxorubicin-loading into nanoparticles for hepatocellular carcinoma cells in vitro and in vivo. J Hepatol 2005, 42:736-743.
8. Hu C.M.J., Zhang L.F. Therapeutic nanoparticles to combat cancer drug resistance. Curr Drug Metab 2009, 10:836-841.
9. Heurtault B., Saulnier P., Pech B., Proust J.E., Benoit J.P. Physico-chemical stability of colloidal lipid particles. Biomaterials 2003, 24:4283-4300.
10. Yang M.H., Li H., Javadi A., Gong S.Q. Multifunctional mesoporous silica nanoparticles as labels for the preparation of ultrasensitive electrochemical immunosensors. Biomaterials 2010, 31:3281-3286.
11. Gan Q., Lu X.Y., Yuan Y., Qian J.C., Zhou H.J., Lu X., et al. A magnetic, reversible pH-responsive nanogated ensemble based on Fe3O4 nanoparticles-capped mesoporous silica. Biomaterials 2011, 32:1932-1942.
12. He Q.J., Zhang J.M., Chen F., Guo L.M., Zhu Z.Y., Shi J.L. An anti-ROS/hepatic fibrosis drug delivery system based on salvianolic acid B loaded mesoporous silica nanoparticles. Biomaterials 2010, 31:7785-7796.
13. Zhu M., Wang H.X., Liu J.Y., He H.L., Hua X.G., He Q.J., et al. A mesoporous silica nanoparticulate/β-TCP/BG composite drug delivery system for osteoarticular tuberculosis therapy. Biomaterials 2011, 32:1986-1995.
14. Horcajada P., Chalati T., Serre C., Gillet B., Sebrie C., Baati T., et al. Porous metal-organic-framework nanoscale carriers as a potential platform for drug delivery and imaging. Nat Mater 2010, 9:172-178.
15. Corma A., Díaz U., Arrica M., Fernández E., Ortega Í Organic-Inorganic nanospheres with responsive molecular gates for drug storage and release. Angew Chem Int Edit 2009, 48:6247-6250.
16. Liu J.W., Stace-Naughton A., Jiang X.M., Brinker C.J. Porous nanoparticle supported lipid bilayers (protocells) as delivery vehicles. J Am Chem Soc 2009, 131:1354-1355.
17. Fahr A., Liu X. Drug delivery strategies for poorly water-soluble drugs. Expert Opin Drug Del 2007, 4:403-416.
18. Riehm H., Biedler J.L. Potentiation of drug effect by Tween 80 in Chinese-Hamster cells resistant to actinomycin-D and daunomycin. Cancer Res 1972, 32:1195-1200.
19. Loe D.W., Sharom F.J. Interaction of multidrug-resistant Chinese-Hamster ovary cells with amphiphiles. Brit J Cancer 1993, 68:342-351.
20. Ito E., Yip K.W., Katz D., Fonseca S.B., Hedley D.W., Chow S., et al. Potential use of cetrimonium bromide as an apoptosis-promoting anticancer agent for head and neck cancer. Mol Pharmacol 2009, 76:969-983.
21. He Q.J., Shi J.L., Chen F., Zhu M., Zhang L.X. An anticancer drug delivery system based on surfactant-templated mesoporous silica nanoparticles. Biomaterials 2010, 31:3335-3346.
22. Zhang W., Shi Y., Chen Y.Z., Ye J., Sha X.Y., Fang X.L. Multifunctional pluronic P123/F127 mixed polymeric micelles loaded with paclitaxel for the treatment of multidrug resistant tumors. Biomaterials 2011, 32:2894-2906.
23. He Q.J., Cui X.Z., Cui F.M., Guo L.M., Shi J.L. Size-controlled synthesis of monodispersed mesoporous silica nano-spheres under a neutral condition. Micropor Mesopor Mater 2009, 117:609-616.
24. He Q.J., Shi J.L., Cui X.Z., Zhao J.J., Chen Y., Zhou J. Rhodamine B-co-condensed subsphaeroidal SBA-15 nanoparticles: facile co-condensation synthesis and excellent fluorescence features. J Mater Chem 2009, 19:3395-3403.
25. Germann U.A. P-glycoprotein - a mediator of multidrug resistance in tumour cells. Eur J Cancer 1996, 32A:927-944.
26. Mealey K.L., Barhoumi R., Burghardt R.C., Safe S., Kochevar D.T. Doxycycline induces expression of P glycoprotein in MCF-7 breast carcinoma cells. Antimicrob Agents Chemother 2002, 46:755-761.
27. Tao Z., Morrow M.P., Asefa T., Sharma K.K., Duncan C., Anan A., et al. Mesoporous silica nanoparticles inhibit cellular respiration. Nano Lett 2008, 8:1517-1526.
28. Lee C.H., Cheng S.H., Huang I.P., Souris J.S., Yang C.S., Mou C.Y., et al. Intracellular pH-responsive mesoporous silica nanoparticles for the controlled release of anticancer chemotherapeutics. Angew Chem Int Edit 2010, 49:8214-8219.
29. Stuart M.A.C., Stuart C., Huck W.T.S., Genzer J., Müller M., Ober C., et al. Emerging applications of stimuli-responsive polymer materials. Nat Mater 2010, 9:101-113.
30. Meng H.A., Xue M., Xia T., Zhao Y.L., Tamanoi F., Stoddart J.F., et al. Autonomous in vitro anticancer drug release from mesoporous silica nanoparticles by pH-sensitive nanovalves. J Am Chem Soc 2010, 132:12690-12697.
31. Zhu Y.F., Shi J.L., Shen W.H., Dong X.P., Feng J.W., Ruan M.L., et al. Stimuli-responsive controlled drug release from a hollow mesoporous silica sphere/polyelectrolyte multilayer core-shell structure. Angew Chem Int Edit 2005, 44:5083-5087.
32. Huo Q.S., Margolese D.I., Ciesla U., Feng P.Y., Gier T.E., Sieger P., et al. Generalized synthesis of periodic surfactant inorganic composite-materials. Nature 1994, 368:317-321.
33. Griffiths J.R. Are cancer-cells acidic. Br J Cancer 1991, 64:425-427.
34. Wike-Hooley J.L., Haveman J., Reinhold H.S. The relevance of tumour pH to the treatment of malignant disease. Radiother Oncol 1984, 2:343-366.